After years of research and clinical testing, we have developed non-invasive, accurate blood tests for early detection of cancer. By making cancer prevention routine, we enable everyone to take control of their own health. The more people take our breakthrough blood tests, the more lives we can save. Life over cancer.

Publications

Prospective clinical study of circulating tumor cells for colorectal cancer screening, ASCO Gastrointestinal Cancers Symposium 2018.

WenSy Tsai, Ashish Nimgaonkar, Oscar Segurado, Ying Chang, Ben Hsieh, HungJen Shao, Jenchia Wu, JrMing Lai, Mana Javey, Drew Watson, Rui Mei

Prospective Clinical Study Of A Prostate Cancer (PCa) Rule-Out Blood Test For PSA Gray Zone Patients Using A Sensitive Circulating Tumor Cell Assay, ASCO Genitourinary Cancers Symposium 2018.

See-Tong Pang, Ying-Hsu Chang, Po-Hung Lin, Ying Chang, Drew Watson, Oscar Segurado, Si-Hong Lu, Jen-chia Wu, Jr-Ming Lai, Hung-Jen Shao, Shih-En Chang, Ben Hsieh, Mana Javey, Rui Mei

Promise of advanced tools for better cancer management: Detection of circulating tumor cells and ctDNA in patients with solid tumors; ASCPALM, Taipei, 2017.

Mana Javey, Hung-Jen Shao, Kevin Tseng, Ben Hsieh, Julian Lucas, Shan-Fu Wu, Rui Mei

Real Time Monitoring of Tumor Evolution and Tailoring Therapy for Cancer Patients; Precision Medicine Conference, CSMUH, Taichung, Taiwan, 2017.

Mana Javey

Oncology solutions: Cancer risk assessment, early detection and personalized treatment selection, Stem Cell Summit, Taipei, Taiwan, 2017.

Mana Javey

Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma, Clin Chem., 2016.

Chang, M.C., Chang, Y.T., Chen, J.Y., Jeng, Y.M., Yang, C.Y., Tien, Y.W., Yang, S.H., Chen, H.L., Liang, T.Y., Wang, C.F., Lee, E.Y., Chang, Y.C. and Lee, W.H.

A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases. Medicine (Baltimore), 2016.

Tien, Y.W., Kuo, H.C., Ho, B.I., Chang, M.C., Chang, Y.T., Cheng, M.F., Chen, H.L., Liang, T.Y., Wang, C.F., Huang, C.Y., Shew, J.Y., Chang, Y.C., Lee, E.Y. and Lee, W.H.

Identifying Cancer Origin Using Circulating Tumor Cells, Cancer Biology and Therapy; Cancer Biol Ther, 2016.

Si-Hong Lu, Wen-Sy Tsai, Ying-Hsu Chang, Teh-Ying Chou, See-Tong Pang, Po-Hung Lin, Chun-Ming Tsai, Ying-Chih Chang

Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection, PLOS 2016.

Jia-Yang Chen , Wen-Sy Tsai , Hung-Jen Shao , Jen-Chia Wu , Jr-Ming Lai , Si-Hong Lu , Tsung-Fu Hung , Chih-Tsung Yang , Liang-Chun Wu , Jinn-Shiun Chen , Wen-Hwa Lee , Ying-Chih Chang

A Novel biomarker for prostate cancer detection in patient with gray zone PSA level, Urological Science, 2016.

Pang, S.-T., Y.-H. Chang, P.-H. Lin, Y.-C. Chang, Y.-s. Lin, B. Hsieh, C.-Y. Liu, C.-K. Chuang, R. Kamal and R. Mei

Introducing a Novel Biomarker for Prostate Cancer Detection in the PSA Gray Zone, SIU 2016

See-Tong Pang et al.

A Novel Biomarker for Prostate Cancer Detection in Patient with Gray Zone PSA Level, TUA 2016.

See-Tong Pang et al.

Genomic Profiling of Tumors For Targeted Therapy Matching Using Novel Liquid Biopsy Platform (SMSEQ), Liquid Biopsy Summit 2016.

Wen-Sy Tsai, Shan-Fu Wu, Julian Lucas, Gangwu Mei, Mana Javey, Rui Mei

Genomic Profiling of Tumors Using Liquid Biopsy to Match Patients to Best Treatment Options, TJCC 2016.

Wen-Sy Tsai, Shan-Fu Wu, Julian Lucas, Gangwu Mei, Mana Javey, Rui Mei

An Innovative Platform for Early Detection of Circulating Tumor Cells for Colorectal Cancer, TJCC 2016.

Wen-Sy Tsai, Ying-Chih Chang, Ben Hsieh, Hung-Jen Shao, Jen-chia Wu, Jr.-Ming Lai, Mana Javey, Rui Mei

Prognostic Impact of Pre-Operative Circulation Tumor Cell Count in Patients with Non-Metastatic Colorectal Cancer, SCRS 2015.

Wen-Sy Tsai

New Frontiers in Personalized Medicine for Colorectal Cancer: Liquid biopsy, Circulating Tumor Cells, ctDNA and Genomics, SCRS 2015.

Mana Javey

Challenges in Isolating Circulating Tumor Cells: From A Technological Perspective, TJCC 2015.

Ying-Chih Chang

Colorectal Cancer Recurrence Monitoring and Detection: Introducing a Breakthrough Blood Test, TSA 2015.

Wen-Sy Tsai

Efficient elusion of viable adhesive cells from a microfluidic system by air foam; Biomicrofluidics, 2014.

Jr-Ming Lai, Hung-Jen Shao, Jen-Chia Wu, Si-Hong Lu, and Ying-Chih Chang

Are We Failing Our Patients? Why Colorectal Cancer is Increasing in Taiwan Despite Greater Awareness, SCRS 2014.

Wen-Sy Tsai

Capturing and Purification of Viable Tumor Cells in Blood, Biomaterials 2013.

Jen-Chia Wu, Po-Yuan Tseng Wen-Sy Tsai, Mei-Ying Liao, Si-Hong Lu, Curtis W. Frank, Jinn-Shiun Chen, Han-Chung Wu, Ying-Chih Chang

Antibody conjugated supported lipid bilayer for capturing and purification of viable tumor cells in blood for subsequent cell culture, Biomaterials, 2013.

Wu JC, Tseng PY, Tsai WS, Liao MY, Lu SH, Frank CW, Chen JS, Wu HC, Chang YC.

Use of surface properties to control the growth and differentiation of mouse fetal liver stem/progenitor cell colonies, Biomacromolecules, 2012.

Tsai HA, Shen CN, Chang YC.

Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients, Nature Scientific Reports, Oncologist, 2012.

Wen-Sy Tsai, Jinn-Shiun Chen, Hung-Jen Shao, Jen-Chia Wu, Jr-Ming Lai, Si-Hong Lu, Tsung-Fu Hung, Yen-Chi Chiu, Jeng-Fu You, Pao-Shiu Hsieh, Chien-Yuh Yeh, Hsin-Yuan Hung, Sum-Fu Chiang, Geng-Ping Lin, Reiping Tang, Ying-Chih Chang

Tethered fibronectin liposomes on supported lipid bilayers as a prepackaged controlled-release platform for cell-based assays, Biomacromolecules, 2012

Tseng PY, Chang YC.

Effects of extracellular matrix protein functionalized fluid membrane on cell adhesion and matrix remodeling, Biomaterials 2010.

Chun-Jen Huang, Po-Yuan Tseng, Ying-Chih Chang

Selection, Enrichment, and Maintenance of Self-Renewal Liver Stem/Progenitor Cells Utilizing Polypeptide Polyelectrolyte Multilayer Films, Biomacromolecules 2010.

Hsuan-Ang Tsai, Ruei-Ren Wu, I-Chi Lee, Hsiao-Yuan Chang, Chia-Ning Shen, Ying-Chih Chang

Type I Collagen-Functionalized Supported Lipid Bilayer as a Cell Culture Platform, Biomacromolecules, 2010.

Chun-Jen Huang, Nam-Joon Cho, Chih-Jung Hsu, Po-Yuan Tseng, Curtis W. Frank, Ying-Chih Chang

The influence of collagen film nanostructure on pulmonary stem cells and collagen-stromal cell interactions, Biomaterials. 2010.

Huang CJ, Chien YL, Ling TY, Cho HC, Yu J, Chang YC.

CellMax Life

CellMax Life is a leading cancer diagnostics company whose mission is to transform how cancer is diagnosed and managed with globally affordable non-invasive tests for early cancer detection and management. CellMax’s unique expertise in both Circulating Tumor Cell and Next Generation Sequencing of DNA and circulating tumor DNA (ctDNA) has enabled multiple highly effective precision medicine solutions for healthy people as well as patients diagnosed with cancer.

U.S. Headquarters

1271 Oakmead Parkway Sunnyvale, CA 94085 Phone: +1 650-564-3905

Taiwan Office

18F-1 Park Street Nangkang, Taipei City (+886) 0800-555-885 (Taiwan)

© 2018 CellMax Life | All Rights Reserved | Terms and Conditions | Privacy Policy

TOP